Na Tolu na Valelailai oqo ni dikevi ni tekinolaji ni bula ena vakavuniwai e Amerika, Isireli kei Japani
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Sa failitaki na kabani oqo e tolu na patents ka kovuta na gacagaca ni kena valelailai ni veiqaravi vakavuniwai.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Iurope, Japani kei Jaina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Na tekinolaji nei OutSense e rawa ni kila na ivurevure ni dra ena ivolacebaceba gastrointestinal.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Me vaka e kaya na OutSense VAKAILESILESI LIU Yfat Scialom, who predicts that “ena kacabote ni veiqaravi vakalivaliva, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, mate ni kete kei na mate ni tikidua ni wai.
Its solution consists of a multispectral optical sensor, e dua na ivurevure ni cina kei na dua na misini ni vakadidike vakaiyayataki ka oka kina e dua na isema WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. iTukutuku e tauri mai na sabolo ni dra, cokovata kei na ikuri ni vakadidike ni gauna mai na drodro ni dra ki na vakatubukawa, vakarautaka na veika matailalai ni kena vakadrodroi na dra. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, E vakaraitaka o OutSense ni CommuniCare, e dua na kabani levu ni veiqaravi vakavuniwai ka sivia na 90 healthcare facilities in the US, ena tekivu pailatetaka na kena tekinolaji ena yabaki oqo. Me ikuri ni pailate oqo, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News